Hovione Technology offers access to simple, patented, globally competitive dry powder inhalers. We provide DPIs for both acute and chronic treatment that maximize simplicity of use, drug delivery performance and industrial manufacturability.
Patented
Low to High Dose
Easy to Manufacture
Economic at Global Scale
Available for Licensing and Supply
Hovione Technology’s capabilities range from inhaler conceptual design to meet specific user and drug needs up to the manufactured, ready to market inhaler.
Integrated Formulation and Device Development
With a 50-year track record, Hovione offers fully integrated inhalation API manufacturing, formulation development adapted to meet innovator or generic product profiles and optimization of formulation and Hovione Technology’s devices together, plus inhaler or capsule filling, packaging and drug product manufacturing.
Our Products
Hovione Technology’s 8Shot™ inhaler for high dose delivery receives the Red Dot Product Design Award
Hovione Technology announces its innovative 8Shot DPI for high dose delivery has received the Red Dot 2020 Product Design Award.
Read moreHovione Technology announces key patent grants for its Large Dose Dry Powder Inhaler
Hovione Technology announces patent grants in key territories of the world for one of its Large Dose dry powder inhaler platforms, the TwinMax DPI.
Read moreHovione Technology completes pilot blister manufacturing for the Papillon DPI
Hovione Technology announces pilot-scale blister manufacturing and filling for its new blister-based dry powder inhaler, the Papillon DPI.
Read more